T 1759/12 (Blood sample testing/BAXALTA) of 25.04.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T175912.20190425
- Date of decision
- 25 April 2019
- Case number
- T 1759/12
- Petition for review of
- -
- Application number
- 98910143.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method of PCR testing of pooled blood samples
- Applicant name
- Baxalta Incorporated
Baxalta GmbH - Opponent name
- Octapharma AG
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 117(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 99European Patent Convention R 115(2)European Patent Convention R 76European Patent Convention R 77Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Admissibility of opposition - yes
Admission of auxiliary request 3 - yes
Hearing of witnesses - no
Main request and auxiliary requests 1 to 3 - inventive step - no
Auxiliary request 4 - requirements of the EPC met - yes - Catchword
- -
- Cited cases
- T 1422/12
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed